For: | Li C, Wu MY, Liang YR, Wu XY. Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma. World J Gastroenterol 2003; 9(11): 2395-2399 [PMID: 14606063 DOI: 10.3748/wjg.v9.i11.2395] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i11/2395.htm |
Number | Citing Articles |
1 |
Mahendar Porika, Radhika Tippani, Anwar Mohammad, Sekhar R Bollam, Sree D Panuganti, Sadanandam Abbagani. Evaluation of Serum Human Telomerase Reverse Transcriptase as a Novel Marker for Cervical Cancer. The International Journal of Biological Markers 2011; 26(1): 22 doi: 10.5301/JBM.2011.6352
|
2 |
Yujuan Kang, Lin Wan, Qin Wang, Yanling Yin, Jiena Liu, Lei Liu, Hao Wu, Lei Zhang, Xin Zhang, Shouping Xu, Da Pang. RETRACTED ARTICLE: Long noncoding RNA SNHG1 promotes TERT expression by sponging miR-18b-5p in breast cancer. Cell & Bioscience 2021; 11(1) doi: 10.1186/s13578-021-00675-5
|
3 |
Ana Pestana, Rui Batista, Ricardo Celestino, Sule Canberk, Manuel Sobrinho-Simões, Paula Soares. Comprehensive Assessment of TERT mRNA Expression across a Large Cohort of Benign and Malignant Thyroid Tumours. Cancers 2020; 12(7): 1846 doi: 10.3390/cancers12071846
|
4 |
Utpal Ghosh, Nitai P. Bhattacharyya. Benzamide and 4‐amino 1,8 naphthalimide treatment inhibit telomerase activity by down‐regulating the expression of telomerase associated protein and inhibiting the poly(ADP‐ribosyl)ation of telomerase reverse transcriptase in cultured cells. The FEBS Journal 2005; 272(16): 4237 doi: 10.1111/j.1742-4658.2005.04837.x
|
5 |
M.L. McCabe, Z. Dlamini. The molecular mechanisms of oesophageal cancer. International Immunopharmacology 2005; 5(7-8): 1113 doi: 10.1016/j.intimp.2004.11.017
|
6 |
Laura Dioni, Mirjam Hoxha, Francesco Nordio, Matteo Bonzini, Letizia Tarantini, Benedetta Albetti, Alice Savarese, Joel Schwartz, Pier Alberto Bertazzi, Pietro Apostoli, Lifang Hou, Andrea Baccarelli. Effects of Short-Term Exposure to Inhalable Particulate Matter on Telomere Length, Telomerase Expression, and Telomerase Methylation in Steel Workers. Environmental Health Perspectives 2011; 119(5): 622 doi: 10.1289/ehp.1002486
|
7 |
Brenna M. McGruder, Donald H. Atha, Wendy Wang, Konrad Huppi, Wen-Qiang Wei, Christian C. Abnet, You-Lin Qiao, Sanford M. Dawsey, Philip R. Taylor, John P. Jakupciak. Real-time telomerase assay of less-invasively collected esophageal cell samples. Cancer Letters 2006; 244(1): 91 doi: 10.1016/j.canlet.2005.12.012
|
8 |
Andrew C. Brane, Trygve O. Tollefsbol. Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 Technology. Cells 2019; 8(2): 186 doi: 10.3390/cells8020186
|
9 |
Meenu Jain, Shaleen Kumar, Punita Lal, Anu Tiwari, Uday C. Ghoshal, Balraj Mittal. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer. Cancer Detection and Prevention 2007; 31(3): 225 doi: 10.1016/j.cdp.2007.04.005
|
10 |
Christina Loukopoulou, Taxiarchis Nikolouzakis, Ioannis Koliarakis, Elena Vakonaki, John Tsiaoussis. Telomere Length and Telomerase Activity as Potential Biomarkers for Gastrointestinal Cancer. Cancers 2024; 16(19): 3370 doi: 10.3390/cancers16193370
|
11 |
Victoria Gonzalo, Anna Petit, Sergi Castellví-Bel, Maria Pellisé, Jenifer Muñoz, Carme Piñol, Francisco Rodríguez-Moranta, Joan Clofent, Francesc Balaguer, M. Dolores Giráldez, Teresa Ocaña, Anna Serradesanferm, Jaume Grau, Josep M. Reñé, Julián Panés, Antoni Castells. Telomerase mRNA expression and immunohistochemical detection as a biomarker of malignant transformation in patients with inflammatory bowel disease. Gastroenterología y Hepatología 2010; 33(4): 288 doi: 10.1016/j.gastrohep.2009.12.011
|
12 |
Mahendar Porika, Radhika Tippani, Sekhar R. Bollam, Sree Divya Panuganti, Christopher Thamidala, Sadanandam Abbagani. Serum human telomerase reverse transcriptase: a novel biomarker for breast cancer diagnosis. International Journal of Clinical Oncology 2011; 16(6): 617 doi: 10.1007/s10147-011-0230-6
|
13 |
Liang Liu, Serene Lai, Lucy G. Andrews, Trygve O. Tollefsbol. Genetic and epigenetic modulation of telomerase activity in development and disease. Gene 2004; 340(1): 1 doi: 10.1016/j.gene.2004.06.011
|
14 |
Yun-Feng Wang, Ke-Jian Guo, Bei-Ting Huang, Yong Liu, Xiao-Yun Tang, Jian-Jun Zhang, Qiang Xia. Inhibitory effects of antisense phosphorothioate oligodeoxynucleotides on pancreatic cancer cell Bxpc-3 telomerase activity and cell growth <italic>in vitro</italic>. World Journal of Gastroenterology 2006; 12(25): 4004-4008 doi: 10.3748/wjg.v12.i25.4004
|
15 |
Kayla A. Lewis, Trygve O. Tollefsbol. Regulation of the Telomerase Reverse Transcriptase Subunit through Epigenetic Mechanisms. Frontiers in Genetics 2016; 7 doi: 10.3389/fgene.2016.00083
|
16 |
Ana Pestana, João Vinagre, Manuel Sobrinho-Simões, Paula Soares. TERT biology and function in cancer: beyond immortalisation. Journal of Molecular Endocrinology 2017; 58(2): R129 doi: 10.1530/JME-16-0195
|
17 |
Serene R. Lai, Amanda P. Cunningham, Vu Q. Huynh, Lucy G. Andrews, Trygve O. Tollefsbol. Evidence of extra-telomeric effects of hTERT and its regulation involving a feedback loop. Experimental Cell Research 2007; 313(2): 322 doi: 10.1016/j.yexcr.2006.10.014
|
18 |
Mohamed JEMF Mabruk, Cathal O’Flatharta. Telomerase: is it the future diagnostic and prognostic tool in human cancer?. Expert Review of Molecular Diagnostics 2005; 5(6): 907 doi: 10.1586/14737159.5.6.907
|
19 |
Hye-Ran Kim, Choong-Won Seo, Keunje Yoo, Sang Jun Han, Jongwan Kim. Yes-associated protein 1 as a prognostic biomarker and its correlation with telomerase in various cancers. Osong Public Health and Research Perspectives 2021; 12(5): 324 doi: 10.24171/j.phrp.2021.0207
|
20 |
Haoli Wang, Jianwen Zhou, Qiong He, Yu Dong, Yanhui Liu. Azidothymidine inhibits cell growth and telomerase activity and induces DNA damage in human esophageal cancer. Molecular Medicine Reports 2017; 15(6): 4055 doi: 10.3892/mmr.2017.6549
|